Skip to content

BBS5 as a robust prognostic biomarker in esophageal squamous cell carcinoma: validation in two independent cohorts.

Aug 2026 · Clinical and Translational Oncology · 0 citations · 20 references
Medicine
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.